|
Recent Developments |
|
19-AUG-14
Parabolic Drugs on Tuesday said that Jagjit Singh Chahal has been appointed as a director on the board of directors of the company.
31-OCT-11
Parabolic Drugs has received an official accreditation from Japan`s ministry of Health, Labour and Welfare, enabling it to manufacture and supply Cephalosporin non sterile drugs to the Japanese market.
05-SEP-11
Parabolic Drugs, a vertically integrated API manufacturer and exporter in India ha... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2016(9) | 31-Mar-2016(12) | 31-Mar-2015(12) | | Net sales | 553.40 | 742.20 | 2287.90 | | Other Income | 0.00 | 3.40 | 0.00 | | Total Income | 553.40 | 745.60 | 2287.90 | | Cost of goods sold | 1130.40 | 3819.80 | 3103.60 | | OPBDIT | -577.00 | -3074.20 | -815.70 | | PAT | -1658.10 | -4851.90 | -3793.20 | | Gross Block | - | - | - | | Equity capital | 618.90 | 618.90 | 618.90 | | EPS (Rs.) | - | - | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | -104.3 | -412.3 | -35.7 | | Net margin (% of OI) | -299.6 | -650.7 | -165.8 |
|
|
Detailed Financials
|
|
|
|
|
